Vpplus SRL
Vpplus reported total assets of €6.19m at the end of the 2025 financial year (annual accounts filed with the NBB on 13 Apr 2026).
The score of Vpplus shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -5 % Total assets +3 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Vpplus's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 13 Apr 2026
- Year ended 31 Dec 2024filed on 02 May 2025
- Year ended 31 Dec 2023filed on 05 Apr 2024
- Year ended 31 Dec 2022filed on 24 May 2023
- Year ended 31 Dec 2021filed on 22 Apr 2022
Vpplus's financial analysis
- Solvency47.3%sector median: 43.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Vpplus
Vpplus's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0439.869.957
- VAT number
- BE0439869957
- Peppol
- Registered · 0208:0439869957 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 10 Feb 1990
- Registered office
- 6666 Houffalize
- Latest accounts
- 2025 · filed on 13 Apr 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Vpplus (SRL) has been based in Houffalize since 1990, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net loss of 48,490 € and equity of €2.93m; its revenue is not published. Its solvency stands at 47.3%, above the median of its sector (43.9%).
Companies similar to Vpplus
Companies in the same business, of comparable size and area, outside its group.
- Green 2 Manufacture of basic pharmaceutical products Ostend · balance sheet €2.01m
- Novalab Wholesale of pharmaceutical and medical goods Uccle · balance sheet 113,734 €
- Xeos Medical Wholesale of pharmaceutical and medical goods Ghent · balance sheet €5.49m
- Curium Belgium Wholesale of pharmaceutical and medical goods Mechelen · balance sheet €5.44m
- Hemotech Belux Wholesale of pharmaceutical and medical goods Koekelare · balance sheet €4.96m
- DD Dental Wholesale of pharmaceutical and medical goods Antwerp · balance sheet €8.75m
- Keypharm Wholesale of pharmaceutical and medical goods Oostkamp · balance sheet €9.49m
- Protex Healthcare Wholesale of pharmaceutical and medical goods Roeselare · balance sheet €2.77m
Frequently asked questions about Vpplus
What is the revenue of Vpplus?
Vpplus files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Vpplus?
In Belgium, the VAT number is the company number prefixed with BE: BE0439869957 for Vpplus, if the company is VAT-registered. Its company number (CBE) is 0439.869.957.
Where is the registered office of Vpplus?
According to the CBE register, the registered office of Vpplus is in 6666 Houffalize.
What is the equity of Vpplus?
At the close of the 2025 financial year, the equity of Vpplus amounts to 2,928,445 €, a solvency of 47.3% of total assets.
Who manages Vpplus?
The register lists 3 active mandates at Vpplus. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Vpplus
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →